Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 123
2021 240
2022 245
2023 131
2024 33

Text availability

Article attribute

Article type

Publication date

Search Results

693 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Ivermectin during the COVID-19 pandemic"
Page 1
Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic.
Castillejos-López M, Torres-Espíndola LM, Huerta-Cruz JC, Flores-Soto E, Romero-Martinez BS, Velázquez-Cruz R, Higuera-Iglesias A, Camarena Á, Torres-Soria AK, Salinas-Lara C, Fernández-Plata R, Alvarado-Vásquez N, Solís-Chagoyán H, Ruiz V, Aquino-Gálvez A. Castillejos-López M, et al. Life (Basel). 2022 Sep 6;12(9):1384. doi: 10.3390/life12091384. Life (Basel). 2022. PMID: 36143420 Free PMC article. Review.
This review compiled the available information regarding the various effects attributed to Ivermectin. The controversy over its use for the treatment of COVID-19 is demonstrated by this report that considers the proposal unfeasible because the therapeutic dos …
This review compiled the available information regarding the various effects attributed to Ivermectin. The controversy over its use f …
Ivermectin for preventing and treating COVID-19.
Popp M, Reis S, Schießer S, Hausinger RI, Stegemann M, Metzendorf MI, Kranke P, Meybohm P, Skoetz N, Weibel S. Popp M, et al. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD015017. doi: 10.1002/14651858.CD015017.pub3. Cochrane Database Syst Rev. 2022. PMID: 35726131 Free PMC article. Review.
Currently, evidence on ivermectin for prevention of SARS-CoV-2 infection and COVID-19 treatment is conflicting. ...Five trials treated participants with moderate COVID-19 (inpatient settings); six treated mild COVID-19 (outpatient …
Currently, evidence on ivermectin for prevention of SARS-CoV-2 infection and COVID-19 treatment is conflicting. ...Five …
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Proper JL, Siegel LK, Klatt NR, Odde DJ, Luke DG, Anderson B, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Biros M, Sherwood NE, Thompson JL, Boulware DR, Murray TA; COVID-OUT Trial Team. Bramante CT, et al. N Engl J Med. 2022 Aug 18;387(7):599-610. doi: 10.1056/NEJMoa2201662. N Engl J Med. 2022. PMID: 36070710 Free PMC article. Clinical Trial.
BACKGROUND: Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. ...CONCLUSIONS: None of the three medications that …
BACKGROUND: Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensi …
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.
Ahmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, Phru CS, Rahman M, Zaman K, Somani J, Yasmin R, Hasnat MA, Kabir A, Aziz AB, Khan WA. Ahmed S, et al. Int J Infect Dis. 2021 Feb;103:214-216. doi: 10.1016/j.ijid.2020.11.191. Epub 2020 Dec 2. Int J Infect Dis. 2021. PMID: 33278625 Free PMC article. Clinical Trial.
A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and safety of ivermectin among adult SARS-CoV-2 patients. The trial included 72 hospitalized patients in Dhaka, Bangladesh, who were assigned to one of three gro …
A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and safety of ivermectin …
Ivermectin for COVID-19: The 2022 Update.
Manu P. Manu P. Am J Ther. 2022 Nov-Dec 01;29(6):e647-e648. doi: 10.1097/MJT.0000000000001577. Am J Ther. 2022. PMID: 36608065 No abstract available.
The Politicization of Ivermectin Tweets During the COVID-19 Pandemic.
Diaz MI, Hanna JJ, Hughes AE, Lehmann CU, Medford RJ. Diaz MI, et al. Open Forum Infect Dis. 2022 Jun 6;9(7):ofac263. doi: 10.1093/ofid/ofac263. eCollection 2022 Jul. Open Forum Infect Dis. 2022. PMID: 35855004 Free PMC article.
BACKGROUND: We explore the ivermectin discourse and sentiment in the United States with a special focus on political leaning through the social media blogging site Twitter. METHODS: We used sentiment analysis and topic modeling to geospatially explore ivermectin Twi …
BACKGROUND: We explore the ivermectin discourse and sentiment in the United States with a special focus on political leaning through …
Effect of Early Treatment with Ivermectin among Patients with Covid-19.
Reis G, Silva EASM, Silva DCM, Thabane L, Milagres AC, Ferreira TS, Dos Santos CVQ, Campos VHS, Nogueira AMR, de Almeida APFG, Callegari ED, Neto ADF, Savassi LCM, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Forrest JI, Ruton H, Sprague S, McKay P, Guo CM, Rowland-Yeo K, Guyatt GH, Boulware DR, Rayner CR, Mills EJ; TOGETHER Investigators. Reis G, et al. N Engl J Med. 2022 May 5;386(18):1721-1731. doi: 10.1056/NEJMoa2115869. Epub 2022 Mar 30. N Engl J Med. 2022. PMID: 35353979 Free PMC article. Clinical Trial.
BACKGROUND: The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome corona …
BACKGROUND: The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatient …
Strongyloides stercoralis.
Czeresnia JM, Weiss LM. Czeresnia JM, et al. Lung. 2022 Apr;200(2):141-148. doi: 10.1007/s00408-022-00528-z. Epub 2022 Apr 9. Lung. 2022. PMID: 35396957 Free PMC article. Review.
Hyperinfection is characterized by exponential increase in parasitic burden, leading to tissue invasion and life-threatening disease and associated bloodstream infections due to enteric organisms. Cases following use of corticosteroids for COVID-19 pneumonia have be …
Hyperinfection is characterized by exponential increase in parasitic burden, leading to tissue invasion and life-threatening disease and ass …
Ivermectin: a mini-review.
Johnson-Arbor K. Johnson-Arbor K. Clin Toxicol (Phila). 2022 May;60(5):571-575. doi: 10.1080/15563650.2022.2043338. Epub 2022 Feb 28. Clin Toxicol (Phila). 2022. PMID: 35225114 Review.
Introduction: Avermectins are common antiparasitic drugs, derived from Streptomyces bacteria that exhibit activity against arthropods and nematodes. Ivermectin, an avermectin derivative, is used as a treatment for parasitic infections in humans and domesticated animals.Dis …
Introduction: Avermectins are common antiparasitic drugs, derived from Streptomyces bacteria that exhibit activity against arthropods and ne …
Ivermectin and the Integrity of Healthcare Evidence During COVID-19.
O'Mathúna DP. O'Mathúna DP. Front Public Health. 2022 Mar 1;10:788972. doi: 10.3389/fpubh.2022.788972. eCollection 2022. Front Public Health. 2022. PMID: 35299698 Free PMC article. Review.
The COVID-19 pandemic has been characterized by a lack of clear evidence to guide healthcare professionals, the public and policymakers. ...The evidence found guides those making treatment decisions, and influences those selecting interventions for further ev …
The COVID-19 pandemic has been characterized by a lack of clear evidence to guide healthcare professionals, the public …
693 results